- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-ASGR1
ASGR1 Polyclonal Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
FC
Conjugaison
PE Fluorescent Dye
N° de cat : PE-11739
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en cytométrie | cellules HepG2, |
Dilution recommandée
Application | Dilution |
---|---|
Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
PE-11739 cible ASGR1 dans les applications de FC et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | ASGR1 Protéine recombinante Ag2310 |
Nom complet | asialoglycoprotein receptor 1 |
Masse moléculaire calculée | 291 aa, 33 kDa |
Poids moléculaire observé | 38-42 kDa |
Numéro d’acquisition GenBank | BC032130 |
Symbole du gène | ASGR1 |
Identification du gène (NCBI) | 432 |
Conjugaison | PE Fluorescent Dye |
Excitation/Emission maxima wavelengths | 496 nm, 565 nm / 578 nm |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS with 0.09% sodium azide and 0.5% BSA |
Conditions de stockage | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. 20ul contiennent 0,1% de BSA. |
Informations générales
Asialoglycoprotein receptor (ASGPR), also known as the hepatic galactose/N-acetylglucosamine (GlcNAc) receptor or Ashwell receptor, is a C-type lectin expressed exclusively in hepatic parenchymal cells. ASGPR consists of two subunits, a major subunit (ASGR1, HL-1) and a minor subunit (ASGR2, HL-2), and specifically recognizes terminal β-linked galactose or GlcNAc on circulating glycoproteins or cells. This receptor plays a critical role in serum glycoprotein homeostasis by mediating the endocytosis and lysosomal degradation of glycoproteins that contain terminal galactose or GlcNAc residues. ASGPR may facilitate hepatic infection by multiple viruses including hepatitis B, and is also a target for liver-specific drug delivery.
Protocole
Product Specific Protocols | |
---|---|
FC protocol for PE ASGR1 antibody PE-11739 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |